Literature DB >> 18644880

Beta-1,2 oligomannose adhesin epitopes are widely distributed over the different families of Candida albicans cell wall mannoproteins and are associated through both N- and O-glycosylation processes.

Chantal Fradin1, Marie Christine Slomianny, Céline Mille, Annick Masset, Raymond Robert, Boualem Sendid, Joachim F Ernst, Jean Claude Michalski, Daniel Poulain.   

Abstract

Beta-1,2-linked mannosides (beta-Mans) are believed to contribute to Candida albicans virulence. The presence of beta-Mans has been chemically established for two molecules (phosphopeptidomannan [PPM] and phospholipomannan) that are noncovalently linked to the cell wall, where they correspond to specific epitopes. However, a large number of cell wall mannoproteins (CWMPs) also express beta-Man epitopes, although their nature and mode of beta-mannosylation are unknown. We therefore used Western blotting to map beta-Man epitopes for the different families of mannoproteins gradually released from the cell wall according to their mode of anchorage (soluble, released by dithiothreitol, beta-1,3 glucan linked, and beta-1,6 glucan linked). Reduction of beta-Man epitope expression occurred after chemical and enzymatic deglycosylation of the different cell wall fractions, as well as in a secreted form of Hwp1, a representative of the CWMPs linked by glycosylphosphatidylinositol remnants. Enzyme-linked immunosorbent assay inhibition tests were performed to assess the presence of beta-Man epitopes in released oligomannosides. A comparison of the results obtained with CWMPs to the results obtained with PPM and the use of mutants with mutations affecting O and N glycosylation demonstrated that both O glycosylation and N glycosylation participate in the association of beta-Mans with the protein moieties of CWMPs. This process, which can alter the function of cell wall molecules and their recognition by the host, is therefore more important and more complex than originally thought, since it differs from the model established previously with PPM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18644880      PMCID: PMC2546831          DOI: 10.1128/IAI.00368-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  74 in total

1.  Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans.

Authors:  M J Gomez; A Torosantucci; S Arancia; B Maras; L Parisi; A Cassone
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies.

Authors:  Y Han; T Kanbe; R Cherniak; J E Cutler
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 3.  An integrated model of the recognition of Candida albicans by the innate immune system.

Authors:  Mihai G Netea; Gordon D Brown; Bart Jan Kullberg; Neil A R Gow
Journal:  Nat Rev Microbiol       Date:  2008-01       Impact factor: 60.633

4.  Cell wall protein mannosylation determines Candida albicans cell surface hydrophobicity.

Authors:  J Masuoka; K C Hazen
Journal:  Microbiology (Reading)       Date:  1997-09       Impact factor: 2.777

5.  Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats.

Authors:  F De Bernardis; M Boccanera; D Adriani; E Spreghini; G Santoni; A Cassone
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  beta-Elimination of O-glycans from glycoproteins transferred to immobilon P membranes: method and some applications.

Authors:  M Duk; M Ugorski; E Lisowska
Journal:  Anal Biochem       Date:  1997-11-01       Impact factor: 3.365

7.  Identification of a new family of genes involved in beta-1,2-mannosylation of glycans in Pichia pastoris and Candida albicans.

Authors:  Céline Mille; Piotr Bobrowicz; Pierre-André Trinel; Huijuan Li; Emmanuel Maes; Yann Guerardel; Chantal Fradin; María Martínez-Esparza; Robert C Davidson; Guilhem Janbon; Daniel Poulain; Stefan Wildt
Journal:  J Biol Chem       Date:  2008-01-30       Impact factor: 5.157

Review 8.  Discovering the secrets of the Candida albicans agglutinin-like sequence (ALS) gene family--a sticky pursuit.

Authors:  Lois L Hoyer; Clayton B Green; Soon-Hwan Oh; Xiaomin Zhao
Journal:  Med Mycol       Date:  2008-02       Impact factor: 4.076

9.  Mapping of beta-1,2-linked oligomannosidic epitopes among glycoconjugates of Candida species.

Authors:  C Cantelli; P A Trinel; A Bernigaud; T Jouault; L Polonelli; D Poulain
Journal:  Microbiology (Reading)       Date:  1995-10       Impact factor: 2.777

10.  Diagnosis of invasive candidiasis by enzyme-linked immunosorbent assay using the N-terminal fragment of Candida albicans hyphal wall protein 1.

Authors:  Ana Laín; Natalia Elguezabal; Sonia Brena; Juan Carlos García-Ruiz; Amalia Del Palacio; María D Moragues; José Pontón
Journal:  BMC Microbiol       Date:  2007-04-21       Impact factor: 3.605

View more
  18 in total

Review 1.  Candida albicans phospholipomannan: a sweet spot for controlling host response/inflammation.

Authors:  Chantal Fradin; Emerson Soares Bernardes; Thierry Jouault
Journal:  Semin Immunopathol       Date:  2014-11-14       Impact factor: 9.623

2.  Candida albicans cell wall glycosylation may be indirectly required for activation of epithelial cell proinflammatory responses.

Authors:  Celia Murciano; David L Moyes; Manohursingh Runglall; Ayesha Islam; Celine Mille; Chantal Fradin; Daniel Poulain; Neil A R Gow; Julian R Naglik
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

Review 3.  System-level impact of mitochondria on fungal virulence: to metabolism and beyond.

Authors:  Richard Calderone; Dongmei Li; Ana Traven
Journal:  FEMS Yeast Res       Date:  2015-05-21       Impact factor: 2.796

4.  Structure-activity relationship study of the plant-derived decapeptide OSIP108 inhibiting Candida albicans biofilm formation.

Authors:  Nicolas Delattin; Katrijn De Brucker; David J Craik; Olivier Cheneval; Barbara De Coninck; Bruno P A Cammue; Karin Thevissen
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

5.  Murine model of dextran sulfate sodium-induced colitis reveals Candida glabrata virulence and contribution of β-mannosyltransferases.

Authors:  Samir Jawhara; Estelle Mogensen; François Maggiotto; Chantal Fradin; Aurore Sarazin; Laurent Dubuquoy; Emmanuel Maes; Yann Guérardel; Guilhem Janbon; Daniel Poulain
Journal:  J Biol Chem       Date:  2012-01-30       Impact factor: 5.157

6.  The Cek1‑mediated MAP kinase pathway regulates exposure of α‑1,2 and β‑1,2‑mannosides in the cell wall of Candida albicans modulating immune recognition.

Authors:  E Román; I Correia; A Salazin; C Fradin; T Jouault; D Poulain; F-T Liu; J Pla
Journal:  Virulence       Date:  2016-05-18       Impact factor: 5.882

7.  Efficient diagnosis of vulvovaginal candidiasis by use of a new rapid immunochromatography test.

Authors:  Agnes Marot-Leblond; Sandrine Nail-Billaud; Françoise Pilon; Bertrand Beucher; Daniel Poulain; Raymond Robert
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

Review 8.  Cell wall-related bionumbers and bioestimates of Saccharomyces cerevisiae and Candida albicans.

Authors:  Frans M Klis; Chris G de Koster; Stanley Brul
Journal:  Eukaryot Cell       Date:  2013-11-15

9.  Glycosylation status of the C. albicans cell wall affects the efficiency of neutrophil phagocytosis and killing but not cytokine signaling.

Authors:  Chirag C Sheth; Rebecca Hall; Leanne Lewis; Alistair J P Brown; Frank C Odds; Lars P Erwig; Neil A R Gow
Journal:  Med Mycol       Date:  2011-01-24       Impact factor: 4.076

10.  β-1,2-Mannosyltransferases 1 and 3 Participate in Yeast and Hyphae O- and N-Linked Mannosylation and Alter Candida albicans Fitness During Infection.

Authors:  Flavie Courjol; Thierry Jouault; Céline Mille; Rebecca Hall; Emmanuel Maes; Boualem Sendid; Jean Maurice Mallet; Yann Guerardel; Neil A R Gow; Daniel Poulain; Chantal Fradin
Journal:  Open Forum Infect Dis       Date:  2015-09-10       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.